Our Technology

Our bioprognostic tests use proprietary sample collection methods, reproducible and precise measurement of senescence biomarkers, and multi-analyte algorithms to predict clinically meaningful, actionable health outcomes. 

Depositphotos_250919500_xl-2015.jpg
Sample Collection
Proprietary sample collection technology to preserve immune components in whole blood for shipping
Tecan-4.png
Senescence Analytes
Assay development and rigorous analytical testing to clinical standards 
Analyst Women Looking At KPI Data On Computer Screen.jpg
Multi-Analyte
Algorithms
Biostatistical and machine learning model development in prospective clinical studies
Doctor and Patient
Clinical Context
Risk report development based on clinical needs and actionability

Sapere Bio has the expertise and technology to bring senescence measurement to the clinic

 

We are the sole source of clinical senescence measurement with the analytical precision, quality assurance, proprietary blood preservation technology, and clinical context required for patient care.

Test%20Tubes_edited.png
medicine, healthcare and cardiology concept - group of doctors with cardiograms, clipboard

A broad portfolio of studies fuels discovery

 

Close collaborations with leading physician scientists lay the scientific foundation for understanding how senescent cell load can be measured and modified to improve clinical outcomes.

Clinical need drives product development

 

Our commercial team conducts extensive market research to define opportunities where senescence measurement can be both actionable and of benefit to a large number of patients.

Our tests are optimized to integrate seamlessly into clinical work flow converting a 'simple' send-out blood test into essential clinical knowledge.

Leading clinical programs are cardiovascular and oncology.

Analyzing Data

>3,900

21

26

clinical studies

centers

samples to-date

indications

16

Our clinical studies are rigorously designed and conducted with prospectively collected samples